Resch U - Search Results

1

The decrease in gamma-tocopherol in plasma and lipoprotein fractions levels off within two days of vitamin E supplementation.

Sundl I, Resch U, Bergmann AR, Roob JM, Winklhofer-Roob BM. Sundl I, et al. Among authors: resch u. Ann N Y Acad Sci. 2004 Dec;1031:378-80. doi: 10.1196/annals.1331.049. Ann N Y Acad Sci. 2004. PMID: 15753174

2

Effects of LDL-immunoapheresis on plasma concentrations of vitamin E and carotenoids in patients with familial hypercholesterolemia.

Cauza E, Jansen M, Resch U, Dunky A, Derfler K, Winklhofer-Roob BM, Kostner K. Cauza E, et al. Among authors: resch u. J Clin Apher. 2004;19(4):174-9. doi: 10.1002/jca.20026. J Clin Apher. 2004. PMID: 15597350

3

Ex vivo low-density lipoprotein oxidizability and in vivo lipid peroxidation in patients on CAPD.

Roob JM, Rabold T, Hayn M, Khoschsorur G, Resch U, Holzer H, Winklhofer-Roob BM. Roob JM, et al. Among authors: resch u. Kidney Int Suppl. 2001 Feb;78:S128-36. doi: 10.1046/j.1523-1755.2001.59780128.x. Kidney Int Suppl. 2001. PMID: 11168998 Free article.

4

Enhanced plasma level of lipid peroxidation in Iranians could be improved by antioxidants supplementation.

Meraji S, Ziouzenkova O, Resch U, Khoschsorur A, Tatzber F, Esterbauer H. Meraji S, et al. Among authors: resch u. Eur J Clin Nutr. 1997 May;51(5):318-25. doi: 10.1038/sj.ejcn.1600405. Eur J Clin Nutr. 1997. PMID: 9152683 Clinical Trial.

5

Antioxidant status in thyroid dysfunction.

Resch U, Helsel G, Tatzber F, Sinzinger H. Resch U, et al. Clin Chem Lab Med. 2002 Nov;40(11):1132-4. doi: 10.1515/CCLM.2002.198. Clin Chem Lab Med. 2002. PMID: 12521231

6

Hypochlorite-modified low-density lipoprotein induces the apoptotic machinery in Jurkat T-cell lines.

Resch U, Semlitsch M, Hammer A, Susani-Etzerodt H, Walczak H, Sattler W, Malle E. Resch U, et al. Biochem Biophys Res Commun. 2011 Jul 15;410(4):895-900. doi: 10.1016/j.bbrc.2011.06.089. Epub 2011 Jun 17. Biochem Biophys Res Commun. 2011. PMID: 21708126 Free PMC article.

7

Reduction of oxidative stress and modulation of autoantibodies against modified low-density lipoprotein after rosuvastatin therapy.

Resch U, Tatzber F, Budinsky A, Sinzinger H. Resch U, et al. Br J Clin Pharmacol. 2006 Mar;61(3):262-74. doi: 10.1111/j.1365-2125.2005.02568.x. Br J Clin Pharmacol. 2006. PMID: 16487219 Free PMC article. Clinical Trial.

8

Inhibition of low-density lipoprotein and high-density lipoprotein oxidation by raloxifene.

Resch U, Mellauner V, Budinsky A, Sinzinger H. Resch U, et al. J Womens Health (Larchmt). 2004 May;13(4):404-11. doi: 10.1089/154099904323087097. J Womens Health (Larchmt). 2004. PMID: 15186657

9

Modification of low-density lipoprotein during radiolabeling with 99mTc using three labeling methods.

Sobal G, Resch U, Tatzber F, Sinzinger H. Sobal G, et al. Among authors: resch u. Q J Nucl Med Mol Imaging. 2006 Dec;50(4):334-43. Q J Nucl Med Mol Imaging. 2006. PMID: 17043631 Free article.

10

Modification of low-density lipoprotein by different radioiodination methods.

Sobal G, Resch U, Sinzinger H. Sobal G, et al. Among authors: resch u. Nucl Med Biol. 2004 Apr;31(3):381-8. doi: 10.1016/j.nucmedbio.2003.10.010. Nucl Med Biol. 2004. PMID: 15028251

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters